Andres Fajardo

Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global

Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global

Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing

Clever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market Uncertainties

Clever Leaves Reports 21% Revenue Growth And 10% Gross Profit Rise In 2Q 2023

Clever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market Uncertainties

Clever Leaves Reports 21% Revenue Growth And 10% Gross Profit Rise In 2Q 2023

Clever Leaves Shares Trading Higher On Its Colombian Cannabis Launching In Australia

Clever Leaves Sells Cannabis Processing Facility In Portugal To Curaleaf's Subsidiary

Andres Fajardo Recent News

Partnership Will Supply Medical Cannabis Extracts To Czech Republic & Switzerland

Global medicinal cannabis company Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) recently completed its inaugural shipment of medical cannabis extracts from Colombia to it

Clever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To Portugal

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GM

Clever Leaves' Q1 Net Loss Drops Significantly After Operating Expenses Slashed By 48%

Global medicinal cannabis company Clever Leaves Holdings Inc.

Clever Leaves Teams Up With Hypera Pharma To Supply CBD-Dominant Oral Solutions For Brazilian Patients

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NADAQ:CLVRW) has entered into a five-year agreement with Hypera Pharma (B3:HYPE3) to supply Clever Leaves’ CBD-dominant oral solutions with the aim of treating various medical conditions and prescribing to Brazilian

Clever Leaves And Praetorian Team Up To Produce Cannabis Genetics In Colombia

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced its commercial agreement with US-based Praetorian Global Inc., to produce cannabis flower and downstream products from Clever Leaves

Clever Leaves Reports Fourth Quarter And Full Year 2022 Results

Clever Leaves Holdings Inc, (NASDAQ: CLVR) reported its financial and operating results on Thursday for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and full year 2022 revenue increased 71% and 90%, respectively. Total annual revenue growth was 16% year-over-year.

Cannabis Operator Makes Extremely Difficult Decision To Lay Off 63 Employees For Expected Savings Of $7M, Spends ~$21M In The Process

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced the wind-down of all operations in Portugal as part of its ongoing restructuring initiatives.

Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021.

Clever Leaves To Bring Its THC Dominant Oral Solution To Peru Via Partnership With Anden Naturals

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced that its partner, Peruvian medicinal cannabis company Anden Naturals, has obtained the sanitary registration

Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) entered into partnership with House of Kush, to be the exclusive grower and distributor of proprietar

These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies.

EXCLUSIVE: Colombia Is About To Legalize Cannabis - And Exports May Land On Your Doorstep Soon, This CEO Says

Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States.

Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) will ship the first commercial export to Israel of high THC flower for medical use from its facility in Portugal through its partnership with <

Clever Leaves, Cantourage Continue To Expand Partnership For Distribution Of Medical Cannabis In Germany

Clever Leaves Holdings Inc. (NASDAQ: CLVR) continues to expand its presence in Germany, via a partnership with European medical cannabis leader Cantourage GmbH. This time, the expansion of their collaboration will include the supply of Clever Leaves’ second pharmaceutical-grade cannabis product, c

Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the first quarter en

Clever Leaves Affiliate Now Fully Licensed To Distribute Medical Cannabis In Germany

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) and its affiliate in Germany, Clever Leaves Germany GmbH, have received all of the required regulatory licenses, per

Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage bio-pharmaceutical company, Biom Therapeutics to provide

Clever Leaves Reports Fourth Quarter And Full Year 2021 Results

Clever Leaves Holdings Inc. (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the fourth quarter and full-year ended December 31, 2021.

InterCure And Clever Leaves Enter Into International Strategic Partnership

Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts

Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group.

Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR) will soon be available for distribution by its partner in Germany, Ethypharm GmbH, a European specialty pharmaceutical company.

Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCann

Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH) has promoted its co-founder and chief strategy officer, Frank Perullo, to president.